{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:50:01Z","timestamp":1786981801065,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T00:00:00Z","timestamp":1488585600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s11255-017-1561-7","type":"journal-article","created":{"date-parts":[[2017,3,4]],"date-time":"2017-03-04T02:15:47Z","timestamp":1488593747000},"page":"961-966","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial"],"prefix":"10.1007","volume":"49","author":[{"given":"Maged","family":"Ragab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed G.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abdel Raheem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"El-Tatawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abo Farha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Elashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,4]]},"reference":[{"issue":"5","key":"1561_CR1","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0022-5347(17)63130-6","volume":"97","author":"PD Zimskind","year":"1967","unstructured":"Zimskind PD, Fetter TR, Wilkerson JL (1967) Clinical use of long-term indwelling silicone rubber ureteral splints inserted cystoscopically. J Urol 97(5):840\u2013844","journal-title":"J Urol"},{"issue":"7","key":"1561_CR2","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1464-410X.2004.4776a.x","volume":"93","author":"H Jeong","year":"2004","unstructured":"Jeong H, Kwak C, Lee SE (2004) Ureteric stenting after ureteroscopy for ureteric stones: a prospective randomized study assessing symptoms and complications. BJU Int 93(7):1032\u20131034 (discussion 4\u20135)","journal-title":"BJU Int"},{"key":"1561_CR3","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/01.ju.0000049198.53424.1d","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Newns N, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG (2003) Ureteral stent symptom questionnaire: development and validation of a multidimensional quality of life measure. J Urol 169:1060\u20131064","journal-title":"J Urol"},{"key":"1561_CR4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0022-5347(17)42282-8","volume":"139","author":"SG Pollard","year":"1988","unstructured":"Pollard SG, Macfarlane R (1988) Symptoms arising from double-J ureteral stents. J Urol 139:37\u201338","journal-title":"J Urol"},{"issue":"2","key":"1561_CR5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.juro.2007.09.026","volume":"179","author":"G Haleblian","year":"2008","unstructured":"Haleblian G, Kijvikai K, de la Rosette J, Preminger G (2008) Ureteral stenting and urinary stone management: a systematic review. J Urol 179(2):424\u2013430","journal-title":"J Urol"},{"issue":"1","key":"1561_CR6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1089\/end.2007.0114","volume":"22","author":"P Hao","year":"2008","unstructured":"Hao P, Li W, Song C, Yan J, Song B, Li L (2008) Clinical evaluation of double-pigtail stent in patients with upper urinary tract diseases: report of 2685 cases. J Endourol 22(1):65\u201370","journal-title":"J Endourol"},{"issue":"6","key":"1561_CR7","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.5489\/cuaj.145","volume":"6","author":"U Kuyumcuoglu","year":"2012","unstructured":"Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgul A (2012) Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 6(6):E234\u2013E237","journal-title":"Can Urol Assoc J"},{"key":"1561_CR8","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1089\/end.2009.0173","volume":"23","author":"SC Park","year":"2009","unstructured":"Park SC, Jung SW, Lee JW, Rim JS (2009) The effects of tolterodine extended release and alfuzosin for the treatment of Double-J stent-related symptoms. J Endourol 23:1913\u20131917","journal-title":"J Endourol"},{"key":"1561_CR9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1590\/S1677-5538.IBJU.2013.06.09","volume":"39","author":"A Tehranchi","year":"2013","unstructured":"Tehranchi A, Rezaei Y, Khalkhali H, Rezaei M (2013) Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial. Int Braz J Urol 39:832\u2013840","journal-title":"Int Braz J Urol"},{"key":"1561_CR10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/752382","author":"E Shalaby","year":"2013","unstructured":"Shalaby E, Ahmed AF, Maarouf A, Yahia I, Ali M, Ghobish A (2013) Randomized controlled trial to compare the safety and efficacy of tamsulosin, solifenacin, and combination of both in treatment of double-j stent-related lower urinary symptoms. Adv Urol. doi: 10.1155\/2013\/752382","journal-title":"Adv Urol"},{"key":"1561_CR11","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4111\/kju.2011.52.7.485","volume":"52","author":"KT Lim","year":"2011","unstructured":"Lim KT, Kim YT, Lee TY, Park SY (2011) Effects of tamsulosin, solifenacin, and combination therapy for the treatment of ureteral stent related discomforts. Korean J Urol 52:485\u2013488","journal-title":"Korean J Urol"},{"issue":"10","key":"1561_CR12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","volume":"49","author":"HN Bockbrader","year":"2010","unstructured":"Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P (2010) A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin. Clin Pharmacokinet 49(10):661\u2013669","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1561_CR13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1526-4637.2009.00796.x","volume":"11","author":"C Toth","year":"2010","unstructured":"Toth C (2010) Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy. Pain Med 11(3):456\u2013465","journal-title":"Pain Med"},{"key":"1561_CR14","first-page":"CD007076","volume":"3","author":"RA Moore","year":"2009","unstructured":"Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ (2009) Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev 3:CD007076","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1561_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","volume":"73","author":"CP Taylor","year":"2007","unstructured":"Taylor CP, Angelotti T, Fauman E (2007) Pharmacology and mechanism of action of pregabalin: the calcium channel alpha 2-delta (alpha 2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 73(2):137\u2013150","journal-title":"Epilepsy Res"},{"issue":"5","key":"1561_CR16","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/S0022-5347(05)64261-9","volume":"168","author":"N Yoshimura","year":"2002","unstructured":"Yoshimura N, Chancellor MB (2002) Current and future pharmacological treatment for overactive bladder. J Urol 168(5):1897\u20131913","journal-title":"J Urol"},{"issue":"2","key":"1561_CR17","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/00007611-200093020-00021","volume":"93","author":"HC Hansen","year":"2000","unstructured":"Hansen HC (2000) Interstitial cystitis and the potential role of gabapentin. South Med J 93(2):238\u2013242","journal-title":"South Med J"},{"issue":"4","key":"1561_CR18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.WNF.0000228174.08885.AB","volume":"29","author":"A Carbone","year":"2006","unstructured":"Carbone A, Palleschi G, Conte A, Bova G, Iacovelli E, Bettolo CM et al (2006) Gabapentin treatment of neurogenic overactive bladder. Clin Neuropharmacol 29(4):206\u2013214","journal-title":"Clin Neuropharmacol"},{"issue":"1","key":"1561_CR19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpurol.2011.10.022","volume":"9","author":"MS Ansari","year":"2013","unstructured":"Ansari MS, Bharti A, Kumar R, Ranjan P, Srivastava A, Kapoor R (2013) Gabapentin: a novel drug as add-on therapy in cases of refractory overactive bladder in children. J Pediatr Urol 9(1):17\u201322","journal-title":"J Pediatr Urol"},{"issue":"4","key":"1561_CR20","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.aju.2014.08.001","volume":"12","author":"AR El-Nahas","year":"2014","unstructured":"El-Nahas AR, Elsaadany MM, Tharwat M, Mosbah A, Metwally AH, Hawary A et al (2014) Validation of the Arabic linguistic version of the Ureteral Stent Symptoms Questionnaire. Arab J Urol 12(4):290\u2013293","journal-title":"Arab J Urol"},{"issue":"2","key":"1561_CR21","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00042307-200403000-00011","volume":"14","author":"BH Chew","year":"2004","unstructured":"Chew BH, Knudsen BE, Denstedt JD (2004) The use of stents in contemporary urology. Curr Opin Urol 14(2):111\u2013115","journal-title":"Curr Opin Urol"},{"key":"1561_CR22","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1089\/end.2008.0037","volume":"22","author":"CH Ho","year":"2008","unstructured":"Ho CH, Chen SC, Chung SD et al (2008) Determining the appropriate length of a double-pigtail ureteral stent by both stent configurations and related symptoms. J Endourol 22:1427\u20131431","journal-title":"J Endourol"},{"issue":"3","key":"1561_CR23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/01.ju.0000048980.33855.90","volume":"169","author":"HB Joshi","year":"2003","unstructured":"Joshi HB, Stainthorpe A, MacDonagh RP, Keeley FX Jr, Timoney AG, Barry MJ (2003) Indwelling ureteral stents: evaluation of symptoms, quality of life and utility. J Urol 169(3):1065\u20131069","journal-title":"J Urol"},{"issue":"1","key":"1561_CR24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpuro0014","volume":"1","author":"BH Chew","year":"2004","unstructured":"Chew BH, Denstedt JD (2004) Technology insight: novel ureteral stent materials and designs. Nat Clin Pract Urol 1(1):44\u201348","journal-title":"Nat Clin Pract Urol"},{"issue":"1","key":"1561_CR25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.07.038","volume":"67","author":"C Deliveliotis","year":"2006","unstructured":"Deliveliotis C, Chrisofos M, Gougousis E, Papatsoris A, Dellis A, Varkarakis IM (2006) Is there a role for alpha 1-blockers in treating double-J stent-related symptoms? Urology 67(1):35\u201339","journal-title":"Urology"},{"issue":"1","key":"1561_CR26","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.juro.2008.09.026","volume":"181","author":"R Beddingfield","year":"2009","unstructured":"Beddingfield R, Pedro RN, Hinck B, Kreidberg C, Feia K, Monga M (2009) Alfuzosin to relieve ureteral stent discomfort: a prospective, randomized, placebo controlled study. J Urol 181(1):170\u2013176","journal-title":"J Urol"},{"issue":"4","key":"1561_CR27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1089\/end.2007.0257","volume":"22","author":"R Damiano","year":"2008","unstructured":"Damiano R, Autorino R, De Sio M, Giacobbe A, Palumbo IM, D\u2019Armiento M (2008) Effect of tamsulosin in preventing ureteral stent-related morbidity: a prospective study. J Endourol 22(4):651\u2013656","journal-title":"J Endourol"},{"key":"1561_CR28","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.juro.2011.04.061","volume":"186","author":"R Yakoubi","year":"2011","unstructured":"Yakoubi R, Lemdani M, Monga M et al (2011) Is there a role for alpha-blockers in ureteral stent related symptoms? A systematic review and meta-analysis. J Urol 186:928\u2013934","journal-title":"J Urol"},{"key":"1561_CR29","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/end.2014.0715","volume":"29","author":"L Zhou","year":"2015","unstructured":"Zhou L, Cai X, Li H, Wang KJ (2015) Effects of \u00ce\u00b1-blockers, antimuscarinics, or combination therapy in relieving ureteral stent-related symptoms: a meta-analysis. J Endourol 29:650\u2013656","journal-title":"J Endourol"},{"issue":"7","key":"1561_CR30","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00345-015-1704-3","volume":"34","author":"AR EL-Nahas","year":"2016","unstructured":"EL-Nahas AR, Tharwat M, Elsaadany M, Mosbah A, Gaballah MA (2016) A randomized controlled trial comparing alpha-blocker (Tamsulosin) and Anticholenergic (Solefenacin) in treatment of ureteral stent related symptoms. World J Urol 34(7):963\u2013968","journal-title":"World J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1561-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1561-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T05:05:51Z","timestamp":1568869551000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1561-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,4]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1561"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1561-7","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,4]]}}}